Mandate

Vinge has advised Borgo AB in its a credit institution license application

Vinge has successfully advised Borgo AB in its license applications as a credit institution. The authorisation was granted by the Swedish FSA on 11 March 2021.

Borgo is an independent mortgage lending company aiming to offer market leading mortgages to Swedish consumers. Borgo’s mortgage products will be offered by ICA Banken, Ikano Bank, Söderberg & Partners and Ålandsbanken, under their brands but with Borgo as lender.

Vinge’s team consisted of, among others Johan Larsson (Corporate), Emma Stuart-Beck, Caroline Krassén and Mikaela Lang (Financial Services), Martin Boström (Commercial Agreements), Paulina Malmberg (Corporate Insurance) and Jolinn Uhlin (Banking & Finance).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024